Related Experiment Videos
Terminal deoxynucleotidyl transferase and human leukemia
Research Communications in Chemical Pathology and Pharmacology
|April 1, 1975
Summary
Terminal deoxynucleotidyl transferase is significantly elevated in acute leukemic lymphoblasts, distinguishing them from normal lymphocytes. This enzyme shows promise as a biomarker for detecting specific types of leukemia.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Terminal deoxynucleotidyl transferase (TdT) is an enzyme involved in DNA synthesis.
- Elevated TdT activity has been observed in certain hematological malignancies.
- Distinguishing between different types of leukemia is crucial for effective treatment.
Purpose of the Study:
- To investigate the activity of Terminal deoxynucleotidyl transferase (TdT) in acute leukemic lymphoblasts.
- To compare TdT activity in leukemic cells with that in normal lymphocytes.
- To evaluate TdT as a potential diagnostic marker for leukemic lymphoblasts.
Main Methods:
- Enzyme activity assays were performed on lymphoblasts from acute leukemia patients.
- TdT and DNA polymerase activities were measured in various cell populations.
- Comparisons were made between leukemic cells, stimulated/unstimulated normal lymphocytes, and cells from other leukemias.
Main Results:
- Terminal deoxynucleotidyl transferase (TdT) activity was several hundred-fold higher in acute leukemic lymphoblasts compared to normal lymphocytes.
- DNA polymerase activity was significantly higher in acute leukemic lymphoblasts and myeloblasts than in unstimulated normal lymphocytes.
- TdT levels were also elevated in leukocytes from other leukemias and in patients in remission, but most pronounced in acute leukemic lymphoblasts.
Conclusions:
- Terminal deoxynucleotidyl transferase (TdT) activity is a highly sensitive indicator for the presence of acute leukemic lymphoblasts.
- TdT serves as a valuable biomarker for the detection and diagnosis of specific leukemia subtypes.
- Further research can explore TdT's role in monitoring leukemia progression and remission.